244 related articles for article (PubMed ID: 27815769)
1. The effect of growth hormone replacement in patients with hypopituitarism on pituitary tumor recurrence, secondary cancer, and stroke.
Jasim S; Alahdab F; Ahmed AT; Tamhane SU; Sharma A; Donegan D; Nippoldt TB; Murad MH
Endocrine; 2017 May; 56(2):267-278. PubMed ID: 27815769
[TBL] [Abstract][Full Text] [Related]
2. Growth Hormone Therapy Does Not Increase the Risk of Craniopharyngioma and Nonfunctioning Pituitary Adenoma Recurrence.
Losa M; Castellino L; Pagnano A; Rossini A; Mortini P; Lanzi R
J Clin Endocrinol Metab; 2020 May; 105(5):. PubMed ID: 32112101
[TBL] [Abstract][Full Text] [Related]
3. Safety aspects of growth hormone replacement.
Waterhouse M; Monson JP
Front Horm Res; 2005; 33():209-221. PubMed ID: 16166764
[No Abstract] [Full Text] [Related]
4. Tumor Recurrence or Regrowth in Adults With Nonfunctioning Pituitary Adenomas Using GH Replacement Therapy.
van Varsseveld NC; van Bunderen CC; Franken AA; Koppeschaar HP; van der Lely AJ; Drent ML
J Clin Endocrinol Metab; 2015 Aug; 100(8):3132-9. PubMed ID: 26057181
[TBL] [Abstract][Full Text] [Related]
5. The effect of growth hormone on pituitary tumour growth.
Herring R; Russell-Jones D
Curr Opin Endocrinol Diabetes Obes; 2010 Aug; 17(4):365-8. PubMed ID: 20498595
[TBL] [Abstract][Full Text] [Related]
6. Comparing progression of non-functioning pituitary adenomas in hypopituitarism patients with and without long-term GH replacement therapy.
Olsson DS; Buchfelder M; Schlaffer S; Bengtsson BA; Jakobsson KE; Johannsson G; Nilsson AG
Eur J Endocrinol; 2009 Nov; 161(5):663-9. PubMed ID: 19734242
[TBL] [Abstract][Full Text] [Related]
7. Replacement therapy with growth hormone and pituitary tumor recurrence: the relevance of the problem.
Losa M; Gatti E; Rossini A; Lanzi R
J Endocrinol Invest; 2008 Sep; 31(9 Suppl):75-8. PubMed ID: 19020392
[TBL] [Abstract][Full Text] [Related]
8. Does GH replacement therapy in adult GH-deficient patients result in recurrence or increase in size of pituitary tumours?
Hatrick AG; Boghalo P; Bingham JB; Ayres AB; Sonksen PH; Russell-Jones DL
Eur J Endocrinol; 2002 Jun; 146(6):807-11. PubMed ID: 12039701
[TBL] [Abstract][Full Text] [Related]
9. Mortality in adults with hypopituitarism: a systematic review and meta-analysis.
Jasim S; Alahdab F; Ahmed AT; Tamhane S; Prokop LJ; Nippoldt TB; Murad MH
Endocrine; 2017 Apr; 56(1):33-42. PubMed ID: 27817141
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone therapy and risk of recurrence/progression in intracranial tumors: a meta-analysis.
Shen L; Sun CM; Li XT; Liu CJ; Zhou YX
Neurol Sci; 2015 Oct; 36(10):1859-67. PubMed ID: 26048536
[TBL] [Abstract][Full Text] [Related]
11. Reviewing the safety of GH replacement therapy in adults.
Stochholm K; Johannsson G
Growth Horm IGF Res; 2015 Aug; 25(4):149-57. PubMed ID: 26117668
[TBL] [Abstract][Full Text] [Related]
12. Management of growth hormone deficiency in adults.
Nilsson AG; Svensson J; Johannsson G
Growth Horm IGF Res; 2007 Dec; 17(6):441-62. PubMed ID: 17629530
[TBL] [Abstract][Full Text] [Related]
13. Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults.
Feldt-Rasmussen U; Wilton P; Jonsson P; ;
Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S51-8. PubMed ID: 15135778
[TBL] [Abstract][Full Text] [Related]
14. Incidence of primary cancers and intracranial tumour recurrences in GH-treated and untreated adult hypopituitary patients: analyses from the Hypopituitary Control and Complications Study.
Child CJ; Conroy D; Zimmermann AG; Woodmansee WW; Erfurth EM; Robison LL
Eur J Endocrinol; 2015 Jun; 172(6):779-90. PubMed ID: 25810462
[TBL] [Abstract][Full Text] [Related]
15. Excess mortality associated with hypopituitarism in adults: a meta-analysis of observational studies.
Pappachan JM; Raskauskiene D; Kutty VR; Clayton RN
J Clin Endocrinol Metab; 2015 Apr; 100(4):1405-11. PubMed ID: 25658016
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of mortality in adults with growth hormone deficiency: Does growth hormone replacement therapy really improve mortality rates?
van Bunderen CC; Olsson DS
Best Pract Res Clin Endocrinol Metab; 2023 Dec; 37(6):101835. PubMed ID: 37914564
[TBL] [Abstract][Full Text] [Related]
17. Fractures in pituitary adenoma patients from the Dutch National Registry of Growth Hormone Treatment in Adults.
van Varsseveld NC; van Bunderen CC; Franken AA; Koppeschaar HP; van der Lely AJ; Drent ML
Pituitary; 2016 Aug; 19(4):381-90. PubMed ID: 27048484
[TBL] [Abstract][Full Text] [Related]
18. Growth hormone deficiency in adults with hypopituitarism-What are the risks and can they be eliminated by therapy?
Johannsson G; Ragnarsson O
J Intern Med; 2021 Dec; 290(6):1180-1193. PubMed ID: 34605087
[TBL] [Abstract][Full Text] [Related]
19. [Growth hormone therapy in adults].
Kann PH
Internist (Berl); 2005 Sep; 46(9):1047-52. PubMed ID: 15928941
[TBL] [Abstract][Full Text] [Related]
20. New Neoplasm During GH Replacement in Adults With Pituitary Deficiency Following Malignancy: A KIMS Analysis.
Krzyzanowska-Mittermayer K; Mattsson AF; Maiter D; Feldt-Rasmussen U; Camacho-Hübner C; Luger A; Abs R
J Clin Endocrinol Metab; 2018 Feb; 103(2):523-531. PubMed ID: 29228199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
